Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

被引：0
|
作者：
Jean-Louis Vincent
Rolf Rossaint
Bruno Riou
Yves Ozier
David Zideman
Donat R Spahn
机构：
[1] Erasme Hospital,Department of Intensive Care
[2] Free University of Brussels,Department of Anaesthesiology of the University Hospital
[3] RWTH,Department of Emergency Medicine and Surgery and Department of Anesthesiology and Critical Care
[4] Hôpital Pitié-Salpêtrière,Department of Anaesthesiology
[5] Assistance Publique-Hôpitaux de Paris,undefined
[6] Université Pierre et Marie Curie,undefined
[7] Service d'Anesthésie-Réanimation Chirurgicale,undefined
[8] Hôpital Cochin,undefined
[9] Assistance publique-Hôpitaux de Paris,undefined
[10] Faculté de Medecine,undefined
[11] Paris-V,undefined
[12] Université Rene-Descartes,undefined
[13] European Resuscitation Council,undefined
[14] ERC Secretariat,undefined
[15] University Hospital Lausanne,undefined
来源：
Critical Care | / 10卷
关键词：
Orthotopic Liver Transplantation; Blunt Trauma; Fresh Freeze Plasma; Recombinant Factor VIIa; rFVIIa Administration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding
    Flynn, Brigid C.
    Steiner, Marie E.
    Mazzeffi, Michael
    ANESTHESIOLOGY, 2023, 139 (02) : 197 - 210
  • [42] The use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery
    Walsham, J
    Fraser, JF
    Mullany, D
    Ziegenfus, M
    Chinthamuneedi, M
    Dunning, J
    Tesar, P
    ANAESTHESIA AND INTENSIVE CARE, 2006, 34 (01) : 13 - 20
  • [43] Use of recombinant activated factor VII (rFVIIa) in pediatric patients with high bleeding risk
    Sciuccati, C.
    Hepner, M.
    Torres, A. Feliu
    Pieroni, G.
    Gomez, J. Avalos
    Bonduel, M.
    HAEMOPHILIA, 2010, 16 : 115 - 115
  • [44] Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery
    Dietrich, W
    Spannagl, M
    ANESTHESIA AND ANALGESIA, 2002, 94 (05): : 1369 - 1370
  • [45] Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures
    Uhrig, Lynn
    Blanot, Stephane
    Baugnon, Thomas
    Orliaguet, Gilles
    Carli, Pierre A.
    Meyer, Philippe G.
    PEDIATRIC CRITICAL CARE MEDICINE, 2007, 8 (06) : 576 - 579
  • [46] THE USE OF RECOMBINANT ACTIVATED FACTOR VII IN A PATIENT WITH UNCONTROLLED BLEEDING FROM THE GASTROINTESTINAL TRACT
    Vitkovic, Radomir
    Petrovic, Ivan
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 246 - 248
  • [47] Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass
    DiDomenico, RJ
    Massad, MG
    Kpodonu, J
    Navarro, RA
    Geha, AS
    CHEST, 2005, 127 (05) : 1828 - 1835
  • [48] Intraoperative Use of Activated Recombinant Factor VII for Refractory Bleeding in Complicated Lung Transplantations
    Felten, Marie-Louise
    Fischler, Marc
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2010, 24 (02) : 382 - 383
  • [49] Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding
    Kandane-Rathnayake, Rangi K.
    Isbister, James P.
    Zatta, Amanda J.
    Aoki, Naomi J.
    Cameron, Peter
    Phillips, Louise E.
    ANZ JOURNAL OF SURGERY, 2013, 83 (03) : 155 - 160
  • [50] Experience with use of recombinant activated factor VII
    Divanon, F
    Hecquard, C
    Borel-Derlon, A
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (02) : 133 - 138
12345